Measuring Outcomes of LASIK and EVO-ICL in Matched Populations

Part of paid clinical trials in Omaha, Nebraska.

Sponsor
Vance Thompson Vision
Study ID
NCT06700460
Status
Recruiting
Apply to this trial

Conditions

  • Myopia

Eligibility Criteria

Sex
ALL
Age
21 Years - 45 Years
Healthy Volunteers
Not accepted

Interventions

  • Laser-assisted in Situ Keratomileusis — DEVICE
    LASIK
  • Implantable Collamer Lens placement — DEVICE
    EVO ICL

Study Details

Evaluating outcomes after bilateral implantation of ICLs or bilateral LASIK as treatment options for the correction or reduction of myopia with or without astigmatism.

Key Dates

Start date
Nov 27, 2024
Status verified
Nov 2024
Primary completion
Feb 28, 2025
Completion
Apr 1, 2025

Study Design

Enrollment
56 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Active Comparator: Laser-assisted in Situ Keratomileusis
    LASIK-Wavefront Optimized
  • Active Comparator: Implantable Collamer Lens placement
    EVO ICL

Primary Outcome Measure

Visual Acuity [ Time Frame: 1 month ]

Central Contacts

Locations (5)

FacilityCityStateZIPSite coordinators
Kugler VisionOmahaNebraska68118-
Cleveland Eye ClinicClevelandOhio44035-
Carolina Eyecare PhysiciansMt. PleasantSouth Carolina29464-
Vance Thompson Vision ClinicSioux FallsSouth Dakota57108-
Slade & Baker VisionHoustonTexas77027-

Find similar trials in Omaha, NE

By research site
Kugler Vision· Omaha, NECleveland Eye Clinic· Cleveland, OHCarolina Eyecare Physicians· Mt. Pleasant, SCVance Thompson Vision Clinic· Sioux Falls, SDSlade & Baker Vision· Houston, TX

Related Studies